![](../images/a.gif) ![](../images/t.gif) ![](../images/h.gif) ![](../images/e.gif) ![](../images/r.gif) ![](../images/o.gif) ![](../images/g.gif) ![](../images/e.gif) ![](../images/n.gif) ![](../images/i.gif) ![](../images/c.gif) ![](../images/s.gif) ![](../images/space.gif) ![](../images/slash.gif)
![](../images/m.gif) ![](../images/e.gif) ![](../images/n.gif) ![](../images/t.gif) ![](../images/u.gif) ![](../images/s.gif) Download This Year's Entry Form Annual Report Highlights: View Competition Class Performance Company/Agency Name: | AtheroGenics    / Mentus | Company/Agency Web Site: | www.atherogenics.com / www.mentus.com | Company Ticker Symbol: | AGIX | Annual Revenue: | Up to $10 Million | Employee Base: | 100 - 1,000 Employees | Core Industry: | Pharmaceuticals | Approximate Number of Pages: (Narrative/Financial Percent) | 32 (31.3%/68.8%) | Award Garnered: | Gold | | | Judging Results | First Impression: | | Report Cover: | | Letter to Shareholders: | | Report Narrative: | | Report Financials: | | Creativity: | | Message Clarity: | | Information Accessibility: | | Total Score: | |
|
![](images/t5888.jpg)
|